Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Neola Medical

1,12 SEK

-2,62 %

Mindre end 1K følgere

NEOLA

First North Stockholm

Medical Equipment & Services

Health Care

Oversigt
Finansielt overblik og estimater
Ejerskab
Investorkonsensus
Sammenligne
-2,62 %
-33,83 %
-52,15 %
-51,94 %
-44,80 %
-49,32 %
-24,41 %
-71,36 %
-79,91 %

Neola Medical operates in the medical technology sector. The company focuses on neonatal care, where it develops medical equipment. Examples of products that the company provides to the healthcare sector include technical monitoring and follow-up of lung capacity in premature infants. In addition to the main product, ancillary products and disposables are offered. The largest operations are found in the Nordic market. Neola Medical was founded in 2016 and is headquartered in Sweden.

Læs mere
Markedsværdi
86,91 mio. SEK
Aktieomsætning
3,35 SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin

Omsætning t

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
12.2
2026

Årsrapport '25

19.5
2026

Delårsrapport Q1'26

Alle
Selskabsmeddelelser
Eksterne analyser
ViserAlle indholdstyper
Pressemeddelelse2.12.2025, 06.00

Neola Medical granted U.S. patent for disposable probes, strengthening future revenue model in target market

Neola Medical
Pressemeddelelse13.11.2025, 06.00

Neola Medical granted Patent in China for reducing optical noise in lung monitoring measurements

Neola Medical
Pressemeddelelse7.11.2025, 07.37

Redeye: Neola Medical (Q3 Review) - Revised timeline

Neola Medical

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Selskabsmeddelelse4.11.2025, 17.57

Neola Medical Q3 Report 2025 – Progressing toward completion of Swedish clinical pilot study and strengthening leadership team

Neola Medical
Selskabsmeddelelse4.11.2025, 17.53

Revised Timeline Announced as Clinical Pilot Study Indicates Robust Safety and Need for Optimization of Neola®

Neola Medical
Pressemeddelelse16.10.2025, 06.00

Neola Medical Strengthens Global IP Portfolio with New Patents Granted in both the U.S. and China for Medical Device Neola®

Neola Medical
Pressemeddelelse1.10.2025, 05.00

Neola Medical’s CEO highlights recent progress in autumn 2025 investor letter

Neola Medical
Selskabsmeddelelse25.9.2025, 05.20

Neola Medical strengthens leadership team with appointment of Clinical Director

Neola Medical
Pressemeddelelse10.9.2025, 05.00

Neola Medical granted European patent enabling lung monitoring beyond preterm born babies

Neola Medical
Pressemeddelelse26.8.2025, 12.26

Redeye: Neola Medical Q2 - Potential share price trigger incoming

Neola Medical
Selskabsmeddelelse25.8.2025, 05.55

Neola Medical Q2 Report 2025 – First U.S. Clinical Study Site Agreement Signed, Key Step in Regulatory Path to Market Authorization

Neola Medical
Pressemeddelelse18.8.2025, 05.00

Neola Medical invites to presentation of the Q2-report 2025

Neola Medical
Pressemeddelelse16.6.2025, 09.00

Neola Medical’s CEO shares clinical progress and recent milestones in summer 2025 investor letter

Neola Medical
Pressemeddelelse10.6.2025, 05.00

Neola Medical Signs Agreement with Leading U.S. Hospital for Pivotal Clinical Study on Preterm Born Babies Following IRB Approval

Neola Medical
Pressemeddelelse22.5.2025, 10.59

Redeye: Neola Medical Q1 - Clinical progress on track

Neola Medical
Selskabsmeddelelse21.5.2025, 06.45

Neola Medical Q1 Report 2025 – Strengthened shareholder base with institutional investors ahead of clinical study start

Neola Medical
Pressemeddelelse21.5.2025, 05.00

First Patient Enrolled in Clinical Pilot Study with Neola® on Preterm Born Babies

Neola Medical
Pressemeddelelse8.5.2025, 05.15

Neola Medical Granted European Patent for Lung Monitoring, Strengthens Protection in Key Markets

Neola Medical
Pressemeddelelse22.4.2025, 10.30

Neola Medical named finalist for Sweden’s new global innovation award at World Expo 2025 in Japan

Neola Medical
Selskabsmeddelelse9.4.2025, 09.45

Neola Medical AB Publishes 2024 Annual Report

Neola Medical
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.